JP2005527477A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005527477A5 JP2005527477A5 JP2003528823A JP2003528823A JP2005527477A5 JP 2005527477 A5 JP2005527477 A5 JP 2005527477A5 JP 2003528823 A JP2003528823 A JP 2003528823A JP 2003528823 A JP2003528823 A JP 2003528823A JP 2005527477 A5 JP2005527477 A5 JP 2005527477A5
- Authority
- JP
- Japan
- Prior art keywords
- disease
- pharmaceutical composition
- mammal
- treating
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 6
- 201000010099 disease Diseases 0.000 claims 5
- 239000008194 pharmaceutical composition Substances 0.000 claims 3
- 241000124008 Mammalia Species 0.000 claims 2
- 150000001875 compounds Chemical class 0.000 claims 2
- 239000000546 pharmaceutical excipient Substances 0.000 claims 2
- 108091032151 5-hydroxytryptamine receptor family Proteins 0.000 claims 1
- 208000024827 Alzheimer disease Diseases 0.000 claims 1
- 208000019901 Anxiety disease Diseases 0.000 claims 1
- 102000014630 G protein-coupled serotonin receptor activity proteins Human genes 0.000 claims 1
- 208000019695 Migraine disease Diseases 0.000 claims 1
- 208000008589 Obesity Diseases 0.000 claims 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 claims 1
- 230000036506 anxiety Effects 0.000 claims 1
- 210000003169 central nervous system Anatomy 0.000 claims 1
- 208000035475 disorder Diseases 0.000 claims 1
- 206010015037 epilepsy Diseases 0.000 claims 1
- 206010027599 migraine Diseases 0.000 claims 1
- 235000020824 obesity Nutrition 0.000 claims 1
- 201000000980 schizophrenia Diseases 0.000 claims 1
- 208000019116 sleep disease Diseases 0.000 claims 1
- 208000020685 sleep-wake disease Diseases 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US32366601P | 2001-09-21 | 2001-09-21 | |
| PCT/US2002/030089 WO2003024976A2 (en) | 2001-09-21 | 2002-09-19 | Tricyclic indole derivatives as 5-ht ligands |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005527477A JP2005527477A (ja) | 2005-09-15 |
| JP2005527477A5 true JP2005527477A5 (https=) | 2006-01-05 |
Family
ID=23260193
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003528823A Withdrawn JP2005527477A (ja) | 2001-09-21 | 2002-09-19 | ５‐ｈｔリガンドとしての三環性インドール誘導体 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US6887868B2 (https=) |
| EP (1) | EP1429776A2 (https=) |
| JP (1) | JP2005527477A (https=) |
| AU (1) | AU2002336749A1 (https=) |
| BR (1) | BR0212676A (https=) |
| CA (1) | CA2460126A1 (https=) |
| MX (1) | MXPA04002615A (https=) |
| WO (1) | WO2003024976A2 (https=) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CL2004000826A1 (es) | 2003-04-25 | 2005-03-04 | Pfizer | Uso de un agonista para el receptor 5-ht2c para preparar un medicamento util en el tratamiento de la incontinencia urinaria provocada por estres, con la condicion de que el agonista no sea 1-[6-cloro-5-(trifluorometil)-2-piridinil]piperazina (org-129 |
| EP2248524A3 (en) | 2004-08-25 | 2011-03-09 | Takeda Pharmaceutical Company Limited | Preventives/remedies for stress urinary incontinence and method of screening the same |
| AR059356A1 (es) * | 2006-02-14 | 2008-03-26 | Astrazeneca Ab | Nuevos radioligandos |
| EP2742936A1 (en) | 2006-05-16 | 2014-06-18 | Takeda Pharmaceutical Company Limited | Fused heterocyclic compound and use thereof |
| EP2789338A3 (en) | 2007-11-15 | 2015-01-14 | Takeda Pharmaceutical Company Limited | Condensed pyridine derivate and use thereof |
| JPWO2011071136A1 (ja) | 2009-12-11 | 2013-04-22 | アステラス製薬株式会社 | 線維筋痛症治療剤 |
| US9216998B2 (en) * | 2012-02-15 | 2015-12-22 | Janssen Pharmaceutica Nv | Tricyclic indole derivatives useful endothelial lipase inhibitors |
| MX2020003242A (es) | 2017-09-22 | 2020-09-18 | Jubilant Epipad LLC | Compuestos heterociclicos como inhibidores de pad. |
| AU2018352142B2 (en) | 2017-10-18 | 2022-08-25 | Jubilant Epipad LLC | Imidazo-pyridine compounds as PAD inhibitors |
| KR20200085836A (ko) | 2017-11-06 | 2020-07-15 | 주빌런트 프로델 엘엘씨 | Pd1/pd-l1 활성화 억제제로서의 피리미딘 유도체 |
| BR112020010322A2 (pt) | 2017-11-24 | 2020-11-17 | Jubilant Episcribe Llc | composto da fórmula i; composto da fórmula ia; composto da fórmula ib; processo de preparação de compostos da fórmula i; composição farmacêutica; método para o tratamento e/ou prevenção de várias doenças; uso dos compostos; método para o tratamento de câncer; e método para o tratamento e/ou prevenção de uma afecção mediada por prmt5 ou um distúrbio proliferativo ou câncer |
| EP3733204A4 (en) | 2017-12-27 | 2021-09-15 | Takeda Pharmaceutical Company Limited | THERAPEUTIC AGENT FOR URINARY INCONTINENCE OF STRESS AND FECAL INCONTINENCE |
| SG11202008950PA (en) | 2018-03-13 | 2020-10-29 | Jubilant Prodel LLC | Bicyclic compounds as inhibitors of pd1/pd-l1 interaction/activation |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3914421A (en) * | 1972-06-19 | 1975-10-21 | Endo Lab | Pyridopyrrolobenzheterocycles for combatting depression |
| US4219550A (en) | 1978-11-09 | 1980-08-26 | E. I. Du Pont De Nemours And Company | Cis- and trans- octahydropyridopyrrolobenzheterocycles |
| NZ227229A (en) * | 1987-12-10 | 1991-03-26 | Duphar Int Res | Indole derivatives and pharmaceutical compositions |
| US4938949A (en) | 1988-09-12 | 1990-07-03 | University Of New York | Treatment of damaged bone marrow and dosage units therefor |
| ZA902794B (en) * | 1989-04-18 | 1991-04-24 | Duphar Int Res | New 3-n substituted carbamoyl-indole derivatives |
| GB8913646D0 (en) * | 1989-06-14 | 1989-08-02 | Glaxo Group Ltd | Chemical compounds |
| HUT61548A (en) * | 1990-08-27 | 1993-01-28 | Sandoz Ag | Process for producing indolonaphthyridine derivatives and pharmaceutical compositions comprising such compounds |
| CA2338866A1 (en) | 1998-07-30 | 2000-02-10 | Japan Tobacco Inc. | Disubstituted maleimide compound and pharmaceutical use thereof |
| PE20010052A1 (es) * | 1999-04-23 | 2001-01-27 | Upjohn Co | Compuestos de azepinindol tetraciclico como agonistas o antagonistas del receptor de 5-ht |
| MXPA01012969A (es) * | 1999-06-15 | 2003-10-14 | Bristol Myers Squibb Pharma Co | Gamma-carbolinas fusionadas de heterociclo sustituido. |
-
2002
- 2002-09-19 CA CA002460126A patent/CA2460126A1/en not_active Abandoned
- 2002-09-19 BR BRPI0212676-1A patent/BR0212676A/pt not_active IP Right Cessation
- 2002-09-19 AU AU2002336749A patent/AU2002336749A1/en not_active Abandoned
- 2002-09-19 JP JP2003528823A patent/JP2005527477A/ja not_active Withdrawn
- 2002-09-19 WO PCT/US2002/030089 patent/WO2003024976A2/en not_active Ceased
- 2002-09-19 EP EP02773527A patent/EP1429776A2/en not_active Withdrawn
- 2002-09-19 US US10/247,756 patent/US6887868B2/en not_active Expired - Fee Related
- 2002-09-19 MX MXPA04002615A patent/MXPA04002615A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005527477A5 (https=) | ||
| JP2003516325A5 (https=) | ||
| JP2007514005A5 (https=) | ||
| JP2003503454A5 (https=) | ||
| YU96502A (sh) | Derivati benzotiazola | |
| JP2005506370A5 (https=) | ||
| JP2007514637A5 (https=) | ||
| JP2011522816A5 (https=) | ||
| JP2007502287A5 (https=) | ||
| JP2007523168A5 (https=) | ||
| NO20050883D0 (no) | Ny fremgangsmate for syntesen (IS)-4,5-dimetoksy-1-(metylaminometyl)-benzocyklobutan og addisjonssalter derav, og anvendelse i syntesen av ivabradin og addisjonssalter derav med en farmasoytisk akseptabel syre | |
| JP2004526788A5 (https=) | ||
| WO2005084655A8 (en) | 1-aminocyclohexane derivatives for the treatment of agitation and other behavioral disorders, especially those associated with alzheimer’s disease | |
| NZ598083A (en) | New compositions of 1-[2-(2,4-dimethyl-phenylsulfanyl)-phenyl]piperazine | |
| JP2005530787A5 (https=) | ||
| JP2023073373A5 (https=) | ||
| JP2008513510A5 (https=) | ||
| JP2003515559A5 (https=) | ||
| WO2006053082A3 (en) | Hydroxybenzoate salts of metanicotine compounds | |
| DE502005010170D1 (de) | Neue langwirksame beta-2-agonisten, und deren verwendung als arzneimittel | |
| WO2007038112A3 (en) | Combination of rosiglitazone and donepezil for improvement of cognitive function | |
| JP2008535834A5 (https=) | ||
| TW200613255A (en) | Therapeutic diphenyl ether ligands | |
| JP2007516278A5 (https=) | ||
| FR2890562B1 (fr) | Utilisation de l'agomelatine pour l'obtention de medicaments destines au traitement des troubles du sommeil chez le patient deprime |